By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
Non infusion8.87B47.90%
Infusion7.48B40.43%
Research and development projects1.51B8.17%
Other business648.53M3.50%
By Industry
Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing16.35B88.32%
Research and development projects1.51B8.17%
Other business648.53M3.50%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
East China5.01B27.08%
Southwest3.7B19.98%
International business2.49B13.44%
Central China2.22B12.00%
North China1.69B9.12%
South China1.43B7.73%
Northwest742.01M4.01%
Other business648.53M3.50%
Northeast China580.96M3.14%
View all
